Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06438159
Other study ID # CARDIO-MBSR
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2024
Est. completion date September 1, 2026

Study information

Verified date May 2024
Source Elsan
Contact Bernard Truong, MD
Phone +33622079508
Email cardiotmkb@me.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiac rehabilitation is a major component of treatment for patients suffering from coronary pathology revealed by myocardial infarction or acute coronary syndrome warranting transluminal coronary angioplasty, as well as in the aftermath of cardiac surgery. A significant proportion of patients in this situation (40%) suffer from varying degrees of anxiety and depression, which are difficult to treat. These impair their quality of life and can make it more difficult for them to take part in the rehabilitation program, compromising the results that can be expected. Finally, they are often associated with lax compliance with medical treatment, less control of risk factors and less regular exercise. Cardiac rehabilitation teams are well aware of this anxiety-depressive picture, and various therapies such as sophrology, relaxation and yoga have been proposed as alternatives to conventional medical treatments to help patients through this period. Among these alternatives is the concept of "Mindfulness-Based Meditation", based on the Mindfulness-Based Stress Reduction (MBSR) protocol described by Dr. JKabat Zinn. It has been the subject of several prospective randomized studies, which have demonstrated that it is suitable for the management of patients in this situation, and that it has measurable beneficial effects on their sense of well-being. To our knowledge, the MBSR program used in cardiac rehabilitation has never been the subject of a randomized comparative study in France to assess its effectiveness on medium- and long-term anxiety-depressive disorders. This is the objective of this study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 74
Est. completion date September 1, 2026
Est. primary completion date September 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Cardiac patients eligible for cardiac rehabilitation, 2. Patient with a Hospital Anxiety and Depression Scale (HADS) score for the anxiety dimension (HADS-A) >7 or a score for the depression dimension (HADS-D) > 7 3. Age = 18 years 4. Affiliated with a social security scheme or beneficiary of such a scheme 5. Patient signed free and informed consent form Exclusion Criteria: 1. Patients already treated for severe psychiatric disorders (major depression, psychosis, schizophrenia) 2. Inability to follow the 8-week MBSR program 3. Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision 4. Medical conditions which may interfere with the conduct of the study and the investigator's judgment, and which may render the patient unfit to participate in the study. 5. Pregnant or breast-feeding patient 6. Refusal to participate in the study or inability to comply with the study protocol for any reason whatsoever

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cardiac rehabilitation with Mindfulness-Based Stress Reduction (MBSR)
The MBSR program is as follows: 8 weekly group sessions of 2h30 led by the mindfulness instructor, Sessions of around 45 minutes a day to be carried out by the patient, at home, for personal training, An intensive day between the 6th and 7th sessions to explore certain practices more intensively, in order to support participants in effectively integrating mindfulness meditation into various life situations.
Conventional cardiac rehabilitation
The usual cardiac rehabilitation program combines exercise training and therapeutic education workshops, with a daily session for four weeks.

Locations

Country Name City State
France Clinique d'Aressy Aressy

Sponsors (1)

Lead Sponsor Collaborator
Elsan

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of HADS anxiety and depression scores HADS (Hospital Anxiety and Depression Scale) is a self questionnaire including 14 items which identifies and quantifies the depression and anxiety from which a person suffers. Baseline and 12 months
Secondary To assess the quality of life The patients' quality of life will be measured by the MQOL-R questionnaire, which is a 14-point tool forming 4 subscales: physical, psychological, existential and social. Baseline, 1 month, 6 months and 12 months
Secondary Medical treatment compliance The patients' compliance to their medical treatment will be measured by the GIRERD self-questionnaire including 6 questions, to assess compliance, i.e. whether treatment is taken regularly and as prescribed. Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "fasting blood glucose" fasting blood glucose (in g/L) Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "glycosylated hemoglobin" glycosylated hemoglobin (% of total hemoglobin) Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "Lipid profile LDLc" Low Density Lipoprotein cholesterol (g/l)
Tobacco consumption (in packs.year)
BMI
Ricci Gagnon scale and 6-minute walk test
Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "Lipid profile HDLc" High Density Lipoprotein cholesterol (g/l) Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "BMI" BMI ( weight and height will be combined to report BMI in kg/m2) Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "effort" 6-minute walk test Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "activity" Ricci Gagnon scale: self questionnaire including 9 questions to evaluate if the subject has an inactive, active or very active profile Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "Tobacco consumption" Tobacco consumption (in packs.year) Baseline, 1 month, 6 months and 12 months
Secondary Changes from baseline of cardiac risk factor "Blood pressure measurement" Blood pressure Baseline, 1 month, 6 months and 12 months
Secondary To assess the patient's anxiety HADS anxiety score Baseline, 1 months and 6 months
Secondary To assess the patient's depression HADS depression score Baseline, 1 months and 6 months
Secondary To evaluate the continuation of formal and informal mindfulness meditation practices in patients who have benefited from the MBSR program. Patients of the MBSR group will be asked two questions :
"Do you still do formal meditation practices?" "Do you still do informal meditation practices?"
3 months, 6 months and 12 months
Secondary To evaluate the patient's "mindfulness" and its impact on vital aspects in patients who have benefited from the MBSR program. FFMQ (Five Facets Mindfulness Questionnaire) questionnaire, which includes 39 questions, which assess the 5 facets which constitute mindfulness as a construct:
Describe the experience: talk about the experience in words.
Acting mindfully: performing actions with active attention to each step.
Non-judgment: absence of positive or negative comments on the thoughts and emotions experienced.
Non-reactivity to private events: allowing thoughts and emotions to exist without responding to them automatically.
Observation: remaining aware and focused on the experience, even when it is aversive or painful.
3 months, 6 months and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05490303 - HeartGuide: Preliminary Study N/A
Completed NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status N/A
Not yet recruiting NCT04511403 - Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Completed NCT02697760 - The CZT Dynamic Myocardial Perfusion Imaging
Terminated NCT05157568 - Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation N/A
Not yet recruiting NCT04160845 - Non-invasive Forehead Skin Temperature in Cardiac Surgery
Completed NCT04500912 - Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population N/A
Recruiting NCT06154473 - Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Not yet recruiting NCT05877755 - Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging N/A
Completed NCT03394859 - Electronic Medical Records and Genomics (eMERGE) Phase III
Recruiting NCT05055830 - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting NCT04374799 - Heparin vs Placebo for Cardiac Catheterization Phase 3
Completed NCT03174106 - Longterm Follow-up of Cardiac Patients With an Smartphone-Application N/A
Recruiting NCT05531253 - Respired Gases in Patients Post Cardiac Surgery
Recruiting NCT04609228 - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
Recruiting NCT06149143 - Cardiac Performance System Data Collection Study - Minnesota
Recruiting NCT05725655 - Hot Water Immersion After Myocardial Infarction N/A
Recruiting NCT06073509 - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Enrolling by invitation NCT04886934 - Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function N/A